Amgen (NASDAQ: AMGN)
Latest
-
Lump sum or DCA, the latest on Ozempic & a baby Berkshire?
Haven't heard much about Ozempic lately? Let us change that and bring you up to speed on some wild developments in the world of weight loss drugs.1 April
-
General
50 Global Investment Opportunities in 2023
Looking for your next investment opportunity in 2023? Look no further! Bloomberg Intelligence has identified 50 companies worth watching in 2023.30th Jan, 2023